Alcohol Screening among Opioid Agonist Patients in a Primary Care Clinic and an Opioid Treatment Program

J Psychoactive Drugs. 2015 Jan-Mar;47(1):65-70. doi: 10.1080/02791072.2014.991859.

Abstract

Problem alcohol use is associated with adverse health and economic outcomes, especially among people in opioid agonist treatment. Screening, brief intervention, and referral to treatment (SBIRT) are effective in reducing alcohol use; however, issues involved in SBIRT implementation among opioid agonist patients are unknown. To assess identification and treatment of alcohol use disorders, we reviewed clinical records of opioid agonist patients screened for an alcohol use disorder in a primary care clinic (n = 208) and in an opioid treatment program (n = 204) over a two-year period. In the primary care clinic, 193 (93%) buprenorphine patients completed an annual alcohol screening and six (3%) had elevated AUDIT scores. In the opioid treatment program, an alcohol abuse or dependence diagnosis was recorded for 54 (27%) methadone patients. Practitioner focus groups were completed in the primary care (n = 4 physicians) and the opioid treatment program (n = 11 counselors) to assess experience with and attitudes towards screening opioid agonist patients for alcohol use disorders. Focus groups suggested that organizational, structural, provider, patient, and community variables hindered or fostered alcohol screening. Alcohol screening is feasible among opioid agonist patients. Effective implementation, however, requires physician training and systematic changes in workflow.

Keywords: SBIRT; agonist treatment; alcohol; family medicine; implementation; opioids.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alcohol-Related Disorders* / complications
  • Alcohol-Related Disorders* / diagnosis
  • Alcohol-Related Disorders* / psychology
  • Analgesics, Opioid
  • Behavior, Addictive / diagnosis
  • Behavior, Addictive / therapy
  • Buprenorphine / therapeutic use*
  • Female
  • Focus Groups
  • Health Services Needs and Demand
  • Humans
  • Male
  • Mass Screening / methods
  • Mass Screening / organization & administration
  • Methadone / therapeutic use*
  • Opiate Substitution Treatment / methods
  • Opioid-Related Disorders* / complications
  • Opioid-Related Disorders* / psychology
  • Opioid-Related Disorders* / therapy
  • Oregon
  • Primary Health Care* / methods
  • Primary Health Care* / standards
  • Psychological Techniques
  • Quality Improvement
  • Substance Abuse Detection / methods

Substances

  • Analgesics, Opioid
  • Buprenorphine
  • Methadone